In the News and Information section you will find the last news about ReachCentrum, including information on our new services and press releases.
Consortia for Biocidal Products Containing Certain Active Substances.
Brussels - ERM and ReachCentrum are collecting interest in the setting up of consortia. These consortia will facilitate cooperation between producers, distributors and formulators wishing to authorise biocidal products on the EU market according to the rules and procedures required by the Biocidal Products Regulation (EU 528/2012 –the ‘BPR’).
ReachCentrum is the chemical industry recognised expert in the delivery of consortium management services. ERM is a leading global provider of environmental, health, safety, regulatory and sustainability related services, with many years of biocide experience helping companies approve active substances and biocidal products in a wide range of chemistries and product types. Together, they have experts in all disciplines with skills to provide scientific and regulatory knowledge to help gain the required authorisations.
From launching this call of interest to final product authorisation, ERM and ReachCentrum will coordinate all aspects of the proposed consortia and provide the technical and regulatory support necessary to ensure consortia members achieve their goals.
ERM and ReachCentrum are planning to launch consortia to support biocidal products containing the following active substances, within the listed Product Types. Biocidal Product Committee decisions to approve these active substances are likely during 2020 meaning that deadlines to submit applications for product authorisation in EU Member States will likely occur during 2022.
In case you would be interested in joining one of these biocidal product consortia, we kindly ask you to express your interest by sending an email to our Team - see contacts below.
|Active Substance||CAS n°||Product Type|
|Active chlorine released from sodium hypochlorite||7681-52-9||11, 12|
|Benzalkonium chloride (BKC)||68424-85-1||1, 2, 3, 4|
|Chrysanthemum cinerariaefolium, extract from open and mature flowers of Tanacetum cinerariifolium obtained with hydrocarbon solvents||89997-63-7||18|
|Chrysanthemum cinerariaefolium extract from open and mature flowers of Tanacetum cinerariifolium obtained with supercritical carbon dioxide||89997-63-7||18|
|Didecyldimethylammonium chloride (DDAC)||7173-51-5||1, 2, 3, 4|
|Hydrogen peroxide||7722-84-1||11, 12|
|Sodium Chloride (NaCl)||7647-14-5||11|
|Symclosene||87-90-1||2, 3, 4, 5, 11|
|Troclosene sodium (NaDCC)||2893-78-9||2, 3, 4, 5, 11|
|Peroxyoctanoic acid||33734-57-5||2, 3, 4|
To discuss your regulatory support requirements, please contact:
Dr Richard Elsmore, Partner & Global Biocide Lead at [email protected]
Dr Sam Wright, Regulatory Affairs Lead at [email protected]
Dr Cecile Rousseau, Partnerat [email protected]
Andrew Goodyear, Partner at [email protected]
Magdalena Urbanowska, Partner (ReachCentrum) at [email protected]Read more
To spend time with our families this holiday season, ReachCentrum general office will be closed from Tuesday, December 24th afternoon through Wednesday, January 1st, 2020. We will resume normal business hours on Thursday, January 2nd 2020. ReachCentrum LoA e-shop office will be closed between December 21st and January 6th 2020 included. We encourage you to place your LoA orders before December 19th, so that we can ensure the processing of your orders and delivery of invoices before December 20th COB.
We will do the necessary to provide tokens, dossiers and Letters of Access for already paid and processed invoices, where a valid token is available, before 20 December 2019 COB. The same applies for responding to your LoA requests sent via email at [email protected].
While you will still be able to be place orders on the platform after December 20th, please take into consideration that they will be processed only starting with January 7th 2020.
We thank you for your cooperation and understanding.
We look forward to working with you in 2020! Happy Holidays!
A new Implementing Regulation ((EU) 2019/1692 of 9 October 2019) concerning the rules applicable to phase-in substances has been published on the Official Journal of the European Union on the 10th of October 2019.
The regulation deals with the following issues:
Finally, please note that Whereas 5 encourages registrants to reinforce their cooperation and to use informal communication platforms to meet their registration and data sharing obligations.
The Implementing Regulation will enter into force on the 20th day following its publication. The text of the Implementing Regulation is available on the Official Journal of the European Union.Read more